PDF herunterladen
Thromb Haemost 2001; 85(05): 938-939
DOI: 10.1055/s-0037-1615774
Letters to the Editor
Schattauer GmbH

Prevalence of the C536T Mutation in the Tissue Factor Pathway Inhibitor (TFPI) Gene among Patients with Venous Thromboembolic Disease

Autor*innen

  • Katia Paciaroni

    1   Department of Hematology, Catholic University, Rome, Italy

  • Elena Rossi

    1   Department of Hematology, Catholic University, Rome, Italy

  • Mario Bazzan

    2   Service of Hematology, Ospedale Evangelico Valdese, Torino, Italy

  • Helen Ireland

    3   Department of Hematology, Charing Cross Hospital, Hammersmith, London, United Kingdom

  • Valerio De Stefano

    1   Department of Hematology, Catholic University, Rome, Italy
Weitere Informationen

Publikationsverlauf

Received 10. Oktober 2001

Accepted after resubmission 22. Dezember 2000

Publikationsdatum:
11. Dezember 2017 (online)

   Lizenzen und Reprints

 

 

  • References

  • 1 Broze Jr GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits factor Xa: insight into its possible mechanism of action. Blood 1988; 71: 335-43.
    PubMedSuche in Google Scholar
  • 2 Kleesiek K, Schmidt M, Gotting C, Brinkmann T, Prohaska W. A first mutation in the human tissue factor pathway inhibitor gene encoding [P151L] TFPI. Blood 1998; 92: 3976-7.
    PubMedSuche in Google Scholar
  • 3 Kleesiek K, Schmidt M, Gotting C, Schwenz B, Lange S, Muller-Berghaus G, Brinkmann T, Prohaska W. The 536C→T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis. Thromb Haemost 1999; 82: 1-5.
    Thieme ConnectPubMedSuche in Google Scholar
  • 4 Evans GD, Langdown J, Brown K, Baglin TP. The C536T transition in the Tissue Factor Pathway Inhibitor gene is not a common cause of venous thromboembolic disease in the UK population. Thromb Haemost 2000; 83: 5 .
    Thieme ConnectPubMedSuche in Google Scholar
  • 5 Gonzalez-Conejero R, Lozano ML, Corral J, Martinez C, Vicente V. The TFPI 536C →■ T mutation is not associated with increased risk for venous or arterial thrombosis. Thromb Haemost 2000; 83: 787-8.
    Thieme ConnectPubMedSuche in Google Scholar
  • 6 De Stefano V, Zappacosta B, Persichilli S, Rossi E, Casorelli I, Paciaroni K, Chiusolo P, Leone AM, Giardina B, Leone G. Prevalence of mild hyper-homocysteinemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G202 0A) in Italian patients with venous throm-boembolic disease. Br J Haematol 1999; 106: 564-8.
    CrossrefPubMedSuche in Google Scholar